Safety and Efficacy of Mirazid for Schistosomiasis Treatment

Clinical trial NCT01529710 · COMPLETED

Trial details

NCT number: NCT01529710
Sponsor: Pharco Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schistosoma Hematobium Infection Schistosomiasis Mansoni

Start date: 2011-12-01
Primary completion: 2012-09-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.